104 related articles for article (PubMed ID: 1322623)
1. Chemotherapy as initial treatment for cervical carcinoma: clinical and tumor marker response.
Leminen A; Alftan H; Stenman UH; Lehtovirta P
Acta Obstet Gynecol Scand; 1992 May; 71(4):293-7. PubMed ID: 1322623
[TBL] [Abstract][Full Text] [Related]
2. [The course of squamous cell carcinoma antigen and CEA as prognostic criteria for response to chemotherapy in cervix cancer].
Meier W; Eiermann W; Stieber P; Fateh-Moghadam A; Hepp H
Geburtshilfe Frauenheilkd; 1989 Dec; 49(12):1050-5. PubMed ID: 2693187
[TBL] [Abstract][Full Text] [Related]
3. Squamous cell carcinoma antigen, tumor-associated trypsin inhibitor, and carcinoembryonic antigen for monitoring cervical cancer.
Pectasides D; Economides N; Bourazanis J; Pozadzizou P; Gogou L; Koutsiouba P; Athanassiou A
Am J Clin Oncol; 1994 Aug; 17(4):307-12. PubMed ID: 8048392
[TBL] [Abstract][Full Text] [Related]
4. Squamous cell carcinoma antigen and carcinoembryonic antigen levels as prognostic factors for the response of cervical carcinoma to chemotherapy.
Meier W; Eiermann W; Stieber P; Fateh-Moghadam A; Schneider A; Hepp H
Gynecol Oncol; 1990 Jul; 38(1):6-11. PubMed ID: 2191907
[TBL] [Abstract][Full Text] [Related]
5. Cervical carcinoma: a comparison of four potential biochemical tumor markers.
Dodd JK; Henry RJ; Tyler JP; Houghton CR
Gynecol Oncol; 1989 Feb; 32(2):248-52. PubMed ID: 2910788
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of squamous cell carcinoma antigen in cancer of the human uterine cervix. Comparison with CEA and CA-125.
Verlooy H; Devos P; Janssens J; Mortelmans L; Gerits M; Bonte J; De Roo M
Gynecol Obstet Invest; 1991; 32(1):55-8. PubMed ID: 1765320
[TBL] [Abstract][Full Text] [Related]
7. [Combination chemotherapy with ifosfamide, 5-fuluorouracil, etoposide and cisplatin for advanced urothelial cancer: the treatment results and significance of tumor marker evaluation in response assessment of chemotherapy].
Maezawa T; Yonese J; Tsukamoto T; Ishii N; Fukui I
Nihon Hinyokika Gakkai Zasshi; 2002 Nov; 93(7):727-35. PubMed ID: 12494517
[TBL] [Abstract][Full Text] [Related]
8. The value of squamous cell carcinoma antigen in patients with locally advanced cervical cancer undergoing neoadjuvant chemotherapy.
Scambia G; Panici PB; Baiocchi G; Amoroso M; Foti E; Greggi S; Mancuso S
Am J Obstet Gynecol; 1991 Feb; 164(2):631-6. PubMed ID: 1992715
[TBL] [Abstract][Full Text] [Related]
9. Tumor markers CA 125, squamous cell carcinoma antigen, and carcinoembryonic antigen in patients with adenocarcinoma of the uterine cervix.
Duk JM; Aalders JG; Fleuren GJ; Krans M; De Bruijn HW
Obstet Gynecol; 1989 Apr; 73(4):661-8. PubMed ID: 2648225
[TBL] [Abstract][Full Text] [Related]
10. [Serum tumor markers SCC, TATI and TPS: value in follow-up of females with cervix cancer].
Joura E; Gitsch G; Kainz C; Fröhlich B; Biegelmayr C; Kölbl H
Gynakol Geburtshilfliche Rundsch; 1992; 32 Suppl 1():115. PubMed ID: 1286308
[No Abstract] [Full Text] [Related]
11. Clinical value of tumor markers for early detection of recurrence in patients with cervical adenocarcinoma and adenosquamous carcinoma.
Tabata T; Takeshima N; Tanaka N; Hirai Y; Hasumi K
Tumour Biol; 2000; 21(6):375-80. PubMed ID: 11006578
[TBL] [Abstract][Full Text] [Related]
12. TPA, TATI, CEA, AFP, beta-HCG, PSA, SCC, and CA 19-9 for monitoring transitional cell carcinoma of the bladder.
Pectasides D; Bafaloucos D; Antoniou F; Gogou L; Economides N; Varthalitis J; Dimitriades M; Kosmidis P; Athanassiou A
Am J Clin Oncol; 1996 Jun; 19(3):271-7. PubMed ID: 8638540
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of pretreatment carcinoembryonic antigen after definitive radiotherapy with or without concurrent chemotherapy for squamous cell carcinoma of the uterine cervix.
Huang EY; Hsu HC; Sun LM; Chanchien CC; Lin H; Chen HC; Tseng CW; Ou YC; Chang HY; Fang FM; Huang YJ; Wang CY; Lu HM; Tsai CC; Ma YY; Fu HC; Wang YM; Wang CJ
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):1105-13. PubMed ID: 20932670
[TBL] [Abstract][Full Text] [Related]
14. [Neoadjuvant chemotherapy with paclitaxel and cisplantin or carboplatin for patients with locally advanced uterine cervical cancer].
Zhang R; Li B; Bai P; Li HJ; Li SM; Wu LY; Li W
Zhonghua Zhong Liu Za Zhi; 2011 Aug; 33(8):616-20. PubMed ID: 22325224
[TBL] [Abstract][Full Text] [Related]
15. The clinical values of squamous cell carcinoma antigen and carcinoembryonic antigen in patients with cervical cancer treated with concurrent chemoradiotherapy.
Yoon SM; Shin KH; Kim JY; Seo SS; Park SY; Kang S; Cho KH
Int J Gynecol Cancer; 2007; 17(4):872-8. PubMed ID: 17343571
[TBL] [Abstract][Full Text] [Related]
16. Squamous cell carcinoma of the colon with an elevated serum squamous cell carcinoma antigen responding to combination chemotherapy.
Copur S; Ledakis P; Novinski D; Mleczko KL; Frankforter S; Bolton M; Fruehling RM; VanWie E; Norvell M; Muhvic J
Clin Colorectal Cancer; 2001 May; 1(1):55-8. PubMed ID: 12445380
[TBL] [Abstract][Full Text] [Related]
17. Transformation of histological tumor type of the cervix expressed in different tumor markers in the serum.
Aalders JG; de Bruijn HW; Oosterhuis JW; Duk JM
Gynecol Oncol; 1990 Jan; 36(1):110-2. PubMed ID: 2295441
[No Abstract] [Full Text] [Related]
18. Serum levels of squamous cell carcinoma antigen and ovarian carcinoma antigen (CA 125) in patients with benign and malignant diseases of the uterine cervix.
Gocze PM; Vahrson HW; Freeman DA
Oncology; 1994; 51(5):430-4. PubMed ID: 8052484
[TBL] [Abstract][Full Text] [Related]
19. CEA, CA 19-9, and CA-50 in monitoring gastric carcinoma.
Pectasides D; Mylonakis A; Kostopoulou M; Papadopoulou M; Triantafillis D; Varthalitis J; Dimitriades M; Athanassiou A
Am J Clin Oncol; 1997 Aug; 20(4):348-53. PubMed ID: 9256887
[TBL] [Abstract][Full Text] [Related]
20. Squamous cell carcinoma antigen (SCC), carcinoembryonic antigen (CEA), and tumour-associated trypsin inhibitor (TATI) for monitoring head and neck cancer.
Pectasides D; Bourazanis J; Economides N; Pozadzidou P; Gogou L; Koutsiouba P; Athanassiou A
Int J Biol Markers; 1993; 8(2):81-7. PubMed ID: 8366300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
